DRUG · Unmapped registry intervention
sacubitril/valsartan
Find medicine records ·
Find other trials using this name
Clinical trial
Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
NCT04929600
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Amlodipine
Normalized identity: amlodipineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hypertensionunresolved
Left Ventricular Hypertrophyunresolved
Interventions
AmlodipineDRUG · verified · RxNorm: amlodipine
Sponsors & collaborators
Shanghai Jiao Tong University School of Medicinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04929600 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.